Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HAPPY-DCB: Huoxin Pill in CHD Patients After DCB Implantation
NCT05489016Phase 4Unknown
- Sponsor
- National Center for Cardiovascular Disease
- Start
- Aug 2022
- Primary completion
- Jan 2024
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
A Phase 4 trial of Huoxin Pill in coronary heart disease (CHD), sponsored by National Center for Cardiovascular Disease. Status: unknown.
02
Drugs
Huoxin Pill
03
Conditions
coronary heart disease (CHD)
Beyond the preview
Go deeper on NCT05489016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05489016.